GlassScriptPhysician profile
Rafael Justiz
NPI 1043226384
$25,081.51
in general payments reported to CMS, 2019-2025
21 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,994 · 2020: $9,436 · 2021: $1,035 · 2022: $988 · 2023: $7,403 · 2024: $1,160 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,450 · Food and Beverage: $2,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,450.00 |
| Food and Beverage | $2,177.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $7,787.35 | 2019-2020 | |
| Aurora Spine, INC. | $7,450.00 | 2023-2025 | Silo Tfx, Zip, Apollo Anterior Cervical Plate System |
| Spinefrontier, INC. | $2,583.45 | 2019 | |
| Abbott Laboratories | $2,521.32 | 2019-2023 | Proclaim |
| Medtronic, INC. | $1,381.36 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Relievant Medsystems, INC. | $1,040.30 | 2019-2022 | |
| Nevro Corp. | $727.18 | 2019-2024 | Senza |
| Vertos Medical, INC. | $404.46 | 2021-2022 | |
| Boston Scientific Corporation | $334.59 | 2020-2024 | Intracept |
| Globus Medical, INC. | $185.65 | 2025 | Vyrsa V1, Senza |
| Spinal Simplicity, LLC | $136.22 | 2021-2024 | Ha Minuteman G3-R |
| Stryker Corporation | $118.67 | 2020 | |
| Saluda Medical Americas, INC. | $114.92 | 2025 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.24 | 2020-2023 | Relistor |
| Vertiflex, INC. | $62.57 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $62.26 | 2019 | |
| Abbvie INC. | $22.64 | 2025 | |
| Grt US Holding, INC. | $19.75 | 2021 | |
| Valinor Pharma, LLC | $15.26 | 2025 | Movantik |
| Nalu Medical, INC. | $13.97 | 2023 | Nalu Neurostimulation System |
| Horizon Therapeutics Plc | $12.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Justiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.